No Data
Achilles Therapeutics Transfers TRACERx Data and MAP Assets to AstraZeneca in $12M Agreement
Express News | Achilles Therapeutics Sells TRACERx And MAP Assets To AstraZeneca For $12M, Transferring Tumor Data And Samples; Concludes Strategic Review With Plans For Workforce And Board Reductions
Press Release: Achilles Therapeutics Announces Sale of Technology Assets to AstraZeneca
Achilles Therapeutics Regains Nasdaq Compliance, Boosting Investor Confidence
Express News | Achilles Therapeutics PLC - Transfer Effective November 19, 2024
Achilles Therapeutics Receives Approval to Transfer to Nasdaq Capital Market
No Data
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}